1. Home
  2. FCN vs RLAY Comparison

FCN vs RLAY Comparison

Compare FCN & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FTI Consulting Inc.

FCN

FTI Consulting Inc.

HOLD

Current Price

$154.95

Market Cap

4.6B

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$20.75

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCN
RLAY
Founded
1982
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
4.1B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
FCN
RLAY
Price
$154.95
$20.75
Analyst Decision
Hold
Strong Buy
Analyst Count
1
10
Target Price
$165.00
$19.50
AVG Volume (30 Days)
520.2K
4.1M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
5.51
31.78
EPS
1.90
N/A
Revenue
$3,788,857,000.00
$15,355,000.00
Revenue This Year
$7.39
N/A
Revenue Next Year
$7.10
$324.03
P/E Ratio
$82.22
N/A
Revenue Growth
2.44
53.44
52 Week Low
$137.65
$3.03
52 Week High
$189.30
$20.20

Technical Indicators

Market Signals
Indicator
FCN
RLAY
Relative Strength Index (RSI) 52.55 72.20
Support Level $150.66 $12.10
Resistance Level $166.46 N/A
Average True Range (ATR) 5.52 1.24
MACD 1.45 0.21
Stochastic Oscillator 74.65 98.78

Price Performance

Historical Comparison
FCN
RLAY

About FCN FTI Consulting Inc.

FTI Consulting Inc is a firm that generates its sales by providing professional business advisory services to customers. The company operates through five segments, namely corporate finance, forensic and litigation consulting, economic consulting, technology, and strategic communications. The company generates the majority of its revenue from the Corporate finance segment. Customers of the company come from a wide array of sectors, including construction, energy and power, environmental, financial institutions, healthcare and life science, insurance, real estate and infrastructure, retail and consumer products, telecom, media, and technology. The majority of the company's revenue is derived from serving customers in the United States.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

Share on Social Networks: